Wegener's Granulomatosis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Hydroxychloroquine in ANCA Vasculitis Evaluation
Conditions: ANCA Associated Vasculitis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Wegener Granulomatosis Interventions: Drug: Hydroxychloroquine; Drug: Placebo Sponsors: Guy's and St Thomas' NHS Foundation Trust; Medical Research Council Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2020 Category: Research Source Type: clinical trials
TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions: Granulomatosis With Polyangiitis; Wegener Granulomatosis Intervention: Drug: Trimethoprim Sulfamethoxazole Sponsor: University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions: Granulomatosis With Polyangiitis (Wegener's) (GPA); Microscopic Polyangiitis (MPA) Interventions: Drug: Glucocorticoids - Standard Dose; Drug: Glucocorticoids - Reduced Dose Sponsor: University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials
